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Tet enzymes (Tet1/2/3) convert 5-methylcytosine
(5mC) to 5-hydroxymethylcytosine (5hmC) and
are dynamically expressed during development.
Whereas loss of individual Tet enzymes or combined
deficiency of Tet1/2 allows for embryogenesis, the
effect of complete loss of Tet activity and 5hmC
marks in development is not established. We have
generated Tet1/2/3 triple-knockout (TKO) mouse
embryonic stem cells (ESCs) and examined their
developmental potential. Combined deficiency of all
three Tets depleted 5hmC and impaired ESC differ-
entiation, as seen in poorly differentiated TKO
embryoid bodies (EBs) and teratomas. Consistent
with impaired differentiation, TKO ESCs contributed
poorly to chimeric embryos, a defect rescued by
Tet1 reexpression, and could not support embryonic
development. Global gene-expression and methyl-
ome analyses of TKO EBs revealed promoter hyper-
methylation and deregulation of genes implicated in
embryonic development and differentiation. These
findings suggest a requirement for Tet- and 5hmC-
mediated DNA demethylation in proper regulation
of gene expression during ESC differentiation and
development.
INTRODUCTION
DNA methylation is a prominent epigenetic modification in the
eukaryotic genome, and dynamic changes in the DNA methyl-
ation landscape are essential for normal regulation of genes dur-
ing development (Smith et al., 2012; Gifford et al., 2013; Xie et al.,
2013). Although it is well defined how the establishment and102 Developmental Cell 29, 102–111, April 14, 2014 ª2014 Elsevier Imaintenance of DNAmethylation mediated by DNAmethyltrans-
ferases are achieved, the mechanisms for removal of this modi-
fication are poorly understood (Wu and Zhang, 2010, 2014). The
Ten eleven translocation (Tet) family of enzymes (Tet1/2/3) has
been implicated in DNA demethylation (Tahiliani et al., 2009;
Ito et al., 2010). These enzymes contain a C-terminal catalytic
domain that has dioxygenase activity and converts 5-methylcy-
tosine (5mC) sequentially to 5-hydroxymethylcytosine (5hmC),
5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) (He
et al., 2011; Ito et al., 2011). Given that DNMT1 recognizes
5hmC poorly, it is believed that this modification promotes pas-
sive DNA demethylation (Wu and Zhang, 2010). However, it has
also been proposed that these modified bases function as inter-
mediates in the process of active DNA demethylation, where
they are enzymatically recognized and removed from the
genome by components of the DNA repair machinery. Because
5hmC has also been found as a stable base in the genome that
reaches significant abundance in several cell types, it may also
serve as a distinct epigenetic mark and not just as a DNA deme-
thylation intermediate (Wu and Zhang, 2010, 2014). Genomic
studies have identified 5hmC as highly abundant in CpG-rich
promoters and gene bodies in mouse embryonic stem cells
(ESCs) (Pastor et al., 2011; Williams et al., 2011) and in enhancer
elements in human ESCs (Stroud et al., 2011), where it may have
critical regulatory roles in orchestrating gene expression.
Tet enzymes and 5hmC are present in various embryonic and
adult cell types, including the zygote (Wossidlo et al., 2011), em-
bryonic stem cells (Ito et al., 2010; Koh et al., 2011), primordial
germ cells (Hajkova et al., 2010), and neurons (Kriaucionis and
Heintz, 2009). Despite their roles in epigenetic regulation of the
genome, notably DNA demethylation, and their presence in
various stages of embryonic and adult development, the physio-
logical relevance of these enzymes has not been well estab-
lished. The recent generation of Tet1, Tet2, and Tet3 single
mutant (Dawlaty et al., 2011; Gu et al., 2011; Li et al., 2011;
Moran-Crusio et al., 2011) and Tet1/2 double-knockout (DKO)
mice and ESCs (Dawlaty et al., 2013) has shed light on the rolesnc.
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development. Both Tet1 and Tet2 are expressed inmouse ESCs,
and depletion of either of these proteins reduces 5hmC levels but
does not affect pluripotency (Dawlaty et al., 2011; Koh et al.,
2011). Tet1 knockout ESCs remain pluripotent and Tet1
knockout mice are viable and fertile despite displaying reduced
body and litter sizes, suggesting a subtle role for Tet1 in embry-
onic development and gametogenesis (Dawlaty et al., 2011).
Like Tet1, Tet2 is also dispensable for embryonic development,
and adult mice are viable and fertile. However, Tet2 deficiency
promotes chronic myelomonocytic leukemia formation in mice
and humans (Li et al., 2011; Moran-Crusio et al., 2011). In
contrast to Tet1 and Tet2, Tet3 is not expressed in ESCs and
is only induced upon differentiation, consistent with its presence
in various differentiated cell types (Dawlaty et al., 2013). In addi-
tion, Tet3 is expressed in the oocytes and zygote, where it par-
ticipates in hydroxylating the paternal pronucleus and promotes
DNA demethylation (Gu et al., 2011; Wossidlo et al., 2011).
Conditional deletion of Tet3 in the oocyte leads to delayed deme-
thylation of the paternal genome and increased developmental
failure, suggesting an essential role for Tet3 during preimplanta-
tion development. Tet3 homozygous mutant mice can develop
to term but die at birth (Gu et al., 2011), suggesting that loss of
Tet3 alone does not block differentiation and embryonic devel-
opment and is possibly compensated for, at least in part, by
Tet1 and Tet2.
Recently, we have shown that combined loss of Tet1 and
Tet2 depletes 5hmC levels in ESCs and germ cells but is
compatible with embryonic development and allows develop-
ment of viable and overtly healthy adult mice (Dawlaty et al.,
2013). However, a large fraction of double-mutant embryos ex-
hibited midgestation defects, perinatal lethality, and compro-
mised imprinting and had reduced 5hmC and increased 5mC
levels. This prompted us to investigate whether Tet3 compen-
sates for loss of Tet1 and Tet2 during development and whether
DNA hydroxymethylation is critical for proper development. To
address this, we have generated Tet1/2/3 triple-knockout
(TKO) mouse ESCs and examined their differentiation and
developmental potential. Our results identify Tet-mediated
epigenetic regulation of developmental genes during differenti-
ation of ESCs and establish a critical role of these enzymes in
differentiation and development.
RESULTS
Generation andCharacterization of Tet Triple-Knockout
Mouse Embryonic Stem Cells
To study the effect of combined deficiency of Tet1, Tet2, and
Tet3 on ESCpluripotency and differentiation potential, we gener-
ated Tet TKOESCs by intercrossing Tet1/2/3 triple-heterozygote
(THet) mice and deriving THet and Tet1–/–jTet2–/–jTet3+/– ESC
lines. The latter cell lines were subsequently targeted to delete
the wild-type (WT) Tet3 allele and obtain Tet TKO ESCs. Geno-
typing by Southern blot confirmed the loss of the WT allele of
all three Tet genes (see Figure S1A available online). All TKO
ESC lines maintained normal ESC morphology, expressed the
pluripotencymarkers Oct4 and Nanog, and could form embryoid
bodies (EBs) (Figure S1B). Further experiments confirmed deple-
tion of all three Tet transcripts (Figure S1C) and proteins (Fig-Deveure 1A) in ESCs and in differentiated cell types such as EBs or
retinoic-acid-treated ESCs. To investigate how loss of Tet en-
zymes affects global 5hmC levels, we applied mass spectrom-
etry to measure levels of 5mC and 5hmC in genomic DNA
isolated from TKO, THet, DKO, and WT EBs (Figure 1B).
Whereas THet and DKO EBs had 50% and 80% reduction
in 5hmC levels, respectively, TKO EBswere completely depleted
of 5hmC, suggesting that Tet1, Tet2, and Tet3 collaborate in
establishing and maintaining 5hmC marks in the genome.
Concomitant with loss of 5hmC, TKO EBs had a subtle increase
in global 5mC levels, suggesting that depletion of 5hmC levels
leads to increased global hypermethylation during ESC differen-
tiation, as observed previously (Dawlaty et al., 2013).
Combined Loss of All Three Tet Enzymes Compromises
Differentiation in Embryoid Body Formation and
Teratoma Assays
To assess how the combined loss of all three Tet proteins affects
differentiation of ESCs, we differentiated TKO and WT or THet
control ESCs to EBs. Although both TKO and control ESCs
formed EBs, histologic examination of TKO EBs revealed poorly
differentiated tissues with substantially fewer differentiated
structures compared to control EBs (Figure 1C). Moreover,
TKO EBs expressed reduced levels of mesodermal and endo-
dermal markers (Figure 1D). The expression levels of these
markers also remained low in late-stage day 15 TKO EBs (Fig-
ure 1E), suggesting that the poor differentiation of TKO ESCs is
not due to a delay in differentiation and rather is likely due to
restricted developmental potency of ESCs. Consistent with
these observations, teratomas derived from WT, THet, and
DKO ESCs contained multiple tissue types of all three germ
layers, whereas TKO teratomas lacked endodermal and
selected mesodermal structures and did not contain more
advanced ectodermal structures such as pigmented neural
epithelium (Figures 1F and 1G). These findings suggest that
Tet enzymes are critical for proper differentiation of ESCs.
TKO ESCs Contribute Poorly to Chimeric Embryos and
Cannot Support Development
To more stringently assess the differentiation potential of TKO
ESCs during embryogenesis, we injected Rosa26-enhanced
green fluorescent protein (EGFP)-targeted TKO and THet control
ESCs, which ubiquitously express EGFP (Figures S2A and S2B),
into blastocysts. After transplantation into foster mothers, em-
bryos were dissected at embryonic day (E)13.5, revealing wide-
spread contribution of THet-R26-EGFP cells to embryos, with
nearly 60% being chimeric and most having high and medium
GFP signals. In contrast, two independent TKO ESC clones
(TKO#26-R26-EGFP and TKO#29-R26-EGFP) exhibited very
poor contribution to developing embryos (Figure 2A), with only
15% being chimeric and displaying an extremely low GFP
signal, mostly in tail, appendages, and dorsolateral areas (Fig-
ures 2A–2C). We also inspected chimeric embryos at E9.5 for
TKO ESC contribution and observed, similar to more advanced
embryos, a significantly lower incidence of chimeric embryos
(35%) as compared to control THet ESCs (92%), with the
majority of TKO chimeric embryos displaying very poor contribu-
tion (Figure 2D). The few embryos that had slightly higher contri-
butions were growth retarded or morphologically defective.lopmental Cell 29, 102–111, April 14, 2014 ª2014 Elsevier Inc. 103
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Figure 1. Loss of 5hmC and Restricted Differentiation Potential of Tet TKO ESCs in Embryoid Body and Teratoma Formation Assays
(A) Confirmation of loss of Tet enzymes in Tet TKO ESCs and differentiated cells by western blot. Asterisks indicate nonspecific bands.
(B) Quantification of 5hmC and 5mC in ESCs and EBs of the indicated genotypes by mass spectrometry.
(C) Sections of paraffin-embedded EBs derived from ESC lines of the indicated genotypes stained with H&E. Insets show higher-magnification images.
(DandE)QuantitativeRT-PCR formarkers of embryonic germ layers inday10EBs (D) andday15EBs (E) of the indicatedgenotypes.Dataarenormalized toGapdh.
(F) Representative images of each embryonic germ layer from H&E-stained sections of teratomas derived from ESCs of the indicated genotypes. N.D., none
detected.
(G) Summary table of the various germ layer tissues detected in teratomas of the indicated genotypes.
Error bars indicate standard deviation. See also Figure S1.
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Figure 2. Limited Contribution of Tet TKO ESCs to Developing Embryos in a Chimera Assay
(A and B) Bright-field and fluorescence images of E13.5 chimeric embryos generated by injecting Rosa26-EGFP-targeted ESCs of the indicated genotypes into
WT blastocysts. The very poor and weaker GFP signal in TKO ESC chimeras is highlighted in the images in (B).
(C) Summary table for all cell lines tested in the chimera assay.
(D) Top: bright-field and fluorescence images of E9.5 chimeric embryos generated by injecting Rosa26-EGFP-targeted ESCs of the indicated genotypes into WT
blastocysts. Bottom: summary table for all cell lines tested in this chimera assay. Asterisks indicate growth-retarded and defective embryos.
(E) Southern blot confirming the negligible-to-no detection of the TKO-Rosa26-EGFP allele in DNA extracted from E13.5 TKO chimeric embryos.
(F) E14.5 chimeric embryos generated by injecting Rosa26-EGFP-targeted ESCs of the indicated genotypes into WT blastocysts. EV, empty vector.
(G) Left: bright-field and fluorescence images of E9.5 4N embryos generated by injecting Rosa26-EGFP-targeted ESCs of the indicated genotypes into 4N WT
blastocysts. Right: summary table for all cell lines tested in the tetraploid complementation assay.
Arrowheads point to poor GFP signal. See also Figure S2.
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Figure 3. Aberrant Promoter Hypermethylation and Deregulation of Developmental Genes in Tet TKO Embryoid Bodies
(A) Schematic of the MeDIP and gene-expression analyses identifying hypermethylated and downregulated genes during differentiation of TKO ESCs.
(B) Scatter plots showing differentially expressed genes in red (upregulated) or green (downregulated) across a panel of TKO EBswhen compared toWT EBs. FC,
fold change.
(C) Gene ontology analysis of differentially expressed genes in TKO EBs.
(D) MeDIP-seq profile of a 3Mb region frommouse chromosome 6with the Hoxa cluster in the center in two independent TKO andWTEB clones as an example of
the general hypermethylation observed in TKO EBs. Enrichments are indicated as normalized read counts.
(legend continued on next page)
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Tet Enzymes and 5hmC in DifferentiationTo exclude the possibility that lack of contribution was due
to silencing of the GFP transgene in the 5hmC-deficient cells,
we assayed for the presence of the donor cells by Southern
blot analysis on whole-embryo DNA using a Rosa26 locus
probe. As shown in Figure 2E, no Rosa-EGFP-targeted DNA
was detected, confirming the lack or at most very low presence
of TKO cells in chimeric embryos. Consistent with these
observations, examination of selected organs from postnatal
mice derived from embryos injected with TKO-R26-EGFP cells
revealed no detectable incorporation of EGFP-positive cells
(Figure S2C).
Both independent clones of TKO ESCs tested in this assay ex-
hibited a similar compromised differentiation potential and poor
contribution to chimeras, strongly suggesting that the observed
phenotypes are due to the engineered Tet enzyme mutations
rather than any unlinked mutations. To further support this, we
overexpressed Tet1 in TKO-R26-EGFP ESCs and found that
ectopic expression of Tet1 in TKO ESCs rescued their differenti-
ation defects and restored contribution to chimeras. Fifty-eight
percent of embryos injected with TKO-R26-EGFP+Tet1 were
chimeric, with the majority of the chimeric embryos having a
medium-to-high degree of contribution and comparable to the
chimeric embryos derived from THet-R26-EGFP ESCs. In
contrast, only 18% of embryos injected with TKO-R26-EGFP
cells transduced with an empty vector were chimeric, with all
embryos having a very poor level of contribution (Figure 2F).
To assess whether the poor contribution of TKO ESCs to a
developing embryo is due to reduced proliferation of these cells,
we quantified the growth rate of TKO ESCs, which was indistin-
guishable from that of control THet ESCs (Figure S2D). This sug-
gests that TKO ESCs are not outcompeted by host inner cell
mass cells due to a proliferation defect. We also tested the ability
of TKO ESCs to support embryonic development in a tetraploid
(4N) complementation assay, where the absolute differentiation
potential of TKO ESCs and their ability to develop into an embryo
can be assessed in the absence of competition of WT host cells.
When analyzed at E9.5, the TKO 4N-injected blastocysts dis-
played only rudimentary structures and failed to support devel-
opment of an embryo proper, in contrast to the three normally
developed THet embryos (Figure 2G). These findings further
support the notion that Tet deficiency compromises the differen-
tiation potential of ESCs and restricts their developmental poten-
tial during embryogenesis.
Deficiency of Tet Enzymes Leads to Aberrant Promoter
Hypermethylation and Deregulation of Developmental
Genes during Differentiation
To determine the effects of loss of Tet enzymes and 5hmCdeple-
tion on DNAmethylation and gene expression during differentia-
tion, we differentiated TKO and WT ESCs to EBs and subjected
them to gene-expression profiling andmethylation analyses (Fig-(E) Analysis of deregulated genes in TKO EBs correlating their expression to the
percentage of deregulated genes in TKO EBs that show hypermethylation compa
(gray) in the gene body or the promoter (±1,000 bp from the TSS).
(F) Gene ontology analysis of all genes with hypermethylated promoter regions
TKO EBs.
(G) Gene ontology analysis of all genes downregulated in TKO EBs that also hav
See also Table S1.
Deveure 3A). We analyzed mRNA levels fromWT and TKO EBs by mi-
croarray (Figure 3B) and found that the majority (1,072/1,801) of
deregulated genes in TKO EBs were downregulated, in contrast
to 729 upregulated genes. Gene ontology analysis revealed that
both up- and downregulated genes in TKO EBs were implicated
in various developmental processes, including embryonic devel-
opment and differentiation (Figure 3C). Nevertheless, the spe-
cific enrichment for developmental categories was much more
significant (lower p values) in the set of downregulated genes
than in the set of upregulated genes. The latter set was associ-
ated with a broader variety of biological functions, which
included development but also cell-cycle replication, DNAmain-
tenance, and proliferation.
Because loss of Tet enzymes promotes global hypermethyla-
tion in TKO EBs (Figure 1B), we analyzed the methylome of TKO
EBs by 5-methylcytosine DNA immunoprecipitation using spe-
cific antibodies against 5mC followed by massive parallel
sequencing (MeDIP-seq). Consistent with the mass spectrom-
etry analysis (Figure 1B), we found a significant increase in total
5mC reads across all chromosomes in TKO EBs compared to
WT EBs. Also, baseline 5mC levels were substantially increased
across the genome, as exemplified by a 3Mb region frommouse
chromosome 6 containing the Hoxa locus (Figure 3D). To further
characterize the TKO methylation landscape, we analyzed the
position-wise coverage of 5mC peaks in gene bodies and pro-
moters (±1 kb of the transcription start site [TSS]) of deregulated
genes in TKO EBs (Figure 3E). We found a weak correlation
between increased gene body methylation and higher gene
expression and a strong enrichment for promoter hypermethyla-
tion among downregulated genes. Thirty-nine percent of genes
with reduced expression in TKO EBs had higher promoter
methylation levels than WT EBs. Gene ontology analyses
revealed that the majority of genes with hypermethylated pro-
moter regions in TKO EBs were implicated in developmental
processes, including embryonic development and cellular
differentiation (Figure 3F). Similarly, downregulated genes with
hypermethylated promoters were enriched for developmental
categories (Figure 3G).
To validate the hypermethylation of deregulated develop-
mental regulators during differentiation of TKO EBs, we applied
locus-specific 454 bisulfite sequencing to analyze promoter
methylation patterns of representative hypermethylated genes
from ourMeDIP analysis (Figure 4A). Analysis of 200–300 bp pro-
moter regions of the downregulated and hypermethylated genes
Emid2, Mall, Gja5, and Tal1 in DNA from TKO EBs and ESCs
confirmed robust hypermethylation of these regions (2- to
5-fold more than controls) during differentiation to EBs but not
in ESCs (Figures 4B and 4C; Figure S3). Two other genes,
Lhx9 and Fgf20, which are hypermethylated but not expressed
in EBs, exhibited increased hypermethylation in both EBs and
ESCs (Figure 4C; Figure S3). Our findings indicate that themethylation status of their promoters or gene bodies. The pie charts show the
red to WT (green), hypomethylation compared to WT (yellow), or do not change
(normalized average read counts >4 in the region ±1,000 bp from the TSS) in
e differentially hypermethylated promoters (TKO versus WT).
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Figure 4. Gene-Specific Bisulfite Sequencing for Validation of Hypermethylation of Deregulated Developmental Genes in Tet TKO Embryoid
Bodies
(A) MeDIP-seq profiles of representative developmental genes in TKO EBs. Enrichments are indicated as normalized read counts. Red boxes indicate the
genomic region analyzed by gene-specific 454 bisulfite sequencing in (B). The green bar indicates a CpG island (as defined by the UCSCGenomeBrowser; http://
genome.ucsc.edu).
(B) Validation of MeDIP data by gene-specific 454 bisulfite sequencing. Results for a 200–300 bp region (red boxes in A) at the promoters of the indicated genes
are shown as heatmaps in which each row represents one sequence read and each column represents an individual CpG site within the analyzed region.
(legend continued on next page)
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Tet Enzymes and 5hmC in Differentiationpromoter regions of many developmental genes become hyper-
methylated in Tet-deficient EBs. A subset of these differentia-
tion-specific genes is active in WT EBs, with their promoter
hypermethylated in TKO EBs, which correlates with reduced
expression and likely causes the observed developmental
phenotypes.
DISCUSSION
Defining the biological significance of Tet proteins and 5hmC
marks during development has been a primary focus of recent
investigations. Here we have established that the loss of all three
Tet enzymes impairs differentiation of ESCs. This phenotype is
less severe than that observed with Dnmt1 mutant ESCs, where
the loss of methyltransferase activity and severely decreased
5mC levels block differentiation and contribution to embryoid
bodies in chimera assays (Lei et al., 1996; Panning and Jaenisch,
1996). In contrast to Dnmt1 mutant cells, Tet TKO ESCs can
form most germ layers in teratoma assays and contribute,
albeit very poorly, to a developing embryo in chimera assays.
This indicates that Tet activity and 5hmC modifications are
essential for proper differentiation during development. Expres-
sion profiles and genome-wide methylation maps of WT and
TKO EBs show that the majority of deregulated genes in TKO
EBs are downregulated, show promoter hypermethylation, and
include developmental regulators that are repressed by DNA
methylation in ESCs (Gifford et al., 2013; Xie et al., 2013).
A subset of these affected genes are also potential targets of
DNA methylation during early embryonic development, where
transition from the blastocyst to epiblast stage of a developing
embryo is associated with modulation of DNA methylation levels
for proper orchestration of gene expression (Smith et al., 2012).
These observations suggest that Tet enzymes confer their bio-
logically critical effects during ESC differentiation by regulating
promoter methylation levels of a subset of developmental
regulators and lineage commitment genes and thus enabling
their activation by differentiation-induced and lineage-specific
demethylation.
Tet3 is not expressed in ESCs, and therefore the epigenetic
landscape of TKO ESCs is likely to be similar to that of Tet1/2
DKO ESCs. Our previous work as well as a recent methylation
analysis of Tet1/2 DKO ESCs (Hackett et al., 2013) have
confirmed increased methylation in these cells. Postnatal sur-
vival of some Tet1/2 double-mutant mice (Dawlaty et al., 2013)
supports the notion that Tet3 activity partially rescues Tet1/2
deficiency. However, as we find here, complete loss of Tet
activity impairs proper promoter demethylation and leads to
silencing of target genes, resulting in reduced developmental
potential of ESCs.
The experiments described here address a long-standing
question in the field regarding the requirements of Tet proteins
and the 5hmC mark in development. Our findings complement
previous studies on the role of DNA methyltransferases in devel-Individual blue boxes indicate methylated and yellow boxes indicate unmethylated
of each interrogated CpG for the analyzed DNA fragment. For a color bar, see (C
(C) Heatmaps for four additional promoter regions of the genes analyzed. Panels
bar shown on the right. Numbers indicate the sequencing coverage.
See also Figure S3.
Deveopment (Li et al., 1992; Okano et al., 1999; Sakaue et al., 2010)
and propose that both DNAmethyltransferases and Tet dioxyge-
nases work in concert to establish and maintain the appropriate
pattern of DNA methylation during ESC differentiation and
development. Recent work has shown differential genomic
localization of Tet1 and Tet2 in ESCs (Huang et al., 2014). It will
be interesting to further investigate the genomic occupancy of
Tet enzymes upon differentiation to establish whether Tet1,
Tet2, and Tet3 bind and activate similar or different classes of
target genes and can substitute for one another. In addition,
further studies are needed to define whether demethylation-in-
dependent functions of 5hmC as a stable epigenetic mark are
also implicated in the epigenetic regulation of development.
This should also entail examining how loss of 5hmC impairs
localization of its readers or binding partners. As this study pri-
marily underpins the requirements of Tet enzymes in differentia-
tion of embryonic stem cells during embryogenesis, future work
using conditional deletion systems will be critical in defining the
exact role of Tet enzymes in regulating the homeostasis of many
adult tissues. This will help to further define physiological impli-
cations of Tet-mediated epigenetic mechanisms of gene regula-
tion in development and diseases including cancer, where Tet
enzymes are mutated or downregulated and 5hmC levels are
significantly reduced.
EXPERIMENTAL PROCEDURES
Derivation and Culture of TKO ESCs
Tet1 and Tet2 knockout alleles have been described previously (Dawlaty et al.,
2013). The Tet3 null allele was generated by deleting exon 4 of Tet3 in V6.5
ESCs (M.M.D. and R.J., unpublished data). Tet1/2/3 triple-heterozygote and
Tet1–/–jTet2–/–jTet3+/– mouse embryonic stem cells were derived by inter-
crossing Tet1/2/3 triple-heterozygote mice. Due to the very low expected
Mendelian frequency of TKO embryos from this cross, we did not derive
TKO ESCs from blastocysts but subjected Tet1–/–jTet2–/–jTet3+/– ESCs to
one round of gene targeting to delete the Tet3 WT allele and generate TKO
ESCs. All ESC lines were expanded on feeders using regular ESC media con-
taining leukemia inhibitory factor (LIF), and were genotyped by PCR and
Southern blot using the protocols and probes previously outlined (Dawlaty
et al., 2013). For the labeling of ESCs with EGFP, an EGFP-pgk-puro cassette
was targeted to the Rosa26 locus and positive clones were screened by
Southern blot.
Chimera and Tetraploid Complementation Assays and Analysis
of Midgestation Embryos
To generate chimeric embryos, 10–12 Rosa26-EGFP-labeled ESCs were
injected into B6D2F1 x B6D2F1 E3.5 WT blastocysts and surgically im-
planted into 2.5 days postcoitum pseudopregnant Swiss Webster female
mice following standard procedures. E9.5, E13.5, or E14.5 embryos were
harvested, dissected, and imaged under a fluorescence dissecting scope
and scored for contribution of TKO ESCs to the developing embryo
based on EGFP signal. The tetraploid complementation assay was per-
formed as described (Wernig et al., 2007) and is briefly explained in
the Supplemental Experimental Procedures. Animal care was in accordance
with institutional guidelines, and was approved by the Committee on Animal
Care, Department of Comparative Medicine, Massachusetts Institute of
Technology.CpG dinucleotides. Panels below the heatmaps show the averagemethylation
). Sequencing coverage (reads) are indicated.
show the average methylation of each interrogated CpG according to the color
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Embryoid bodies were formed from ESCs following standard hanging-
drop methods as explained previously (Dawlaty et al., 2011). EBs were main-
tained in fetal bovine serum media –LIF for 10 days (or 15 days) before use
for analysis. Teratoma assays and histological analyses of tissues and EBs
were performed exactly as explained before (Dawlaty et al., 2013). Hematox-
ylin and eosin (H&E)-stained sections of teratomas were examined and
scored for the presence or absence of tissue types from the three germ
layers.
Quantification of 5hmC and 5mC
Combined liquid chromatography-tandem mass spectrometry with multiple
reaction monitoring (LC-MS/MS-MRM) was applied to quantify 5hmC and
5mC levels in DNA extracted from ESCs or EBs as described previously (Le
et al., 2011; Dawlaty et al., 2013).
Microarray Analysis
RNAwas extracted from day 10 embryoid bodies using a QIAGEN RNeasy Kit,
labeledwithCy3, and hybridized to Agilent arrays. Two technical replicas ofWT
EBs (two samples in total) and two technical replicas of two independent TKO
EBs (four TKO samples in total) were hybridized to a Mouse GE 8x60K
Microarray. Arrays were normalized by quantile normalization. All probes for
the same gene were summarized by mean before assaying for differential
expression by a moderated t test corrected for false discovery rate, as imple-
mentedby the limmapackage inBioconductor (http://www.bioconductor.org).
The cutoff used to select differentially expressed genes was fold change >2
and adjusted p value <0.01. Gene ontology analyses were performed using In-
genuity Pathway Analysis software (http://www.ingenuity.com/products/ipa).
454 DNA Bisulfite Sequencing
Deep DNA bisulfite sequencing was performed as described previously (Gro¨n-
niger et al., 2010). Genomic DNA from WT and TKO ESCs and WT and TKO
embryoid bodies was bisulfite treated using the EpiTect Bisulfite Kit (QIAGEN)
according to the manufacturer’s instructions. Treated DNA was amplified with
sequence-specific primers (described in Supplemental Experimental Proce-
dures) containing cell-type-specific barcodes and standard 454 linker se-
quences. PCR products of 200–300 bp were gel extracted using the peqGOLD
Extraction Kit (Peqlab). For sequencing, equimolar amounts of all amplicons
were combined in a single tube and processed on a GS Junior sequencer
(Roche) according to the manufacturer’s instructions. Sequence reads were
aligned and are displayed as color-coded heatmaps.
MeDIP-Seq, Mapping of Sequencing Data, and Calculation of
Methylation Levels
MeDIP-seq was performed as described (Bocker et al., 2012) but significantly
adapted and scaled down to smaller starting amounts according to the proto-
col by Taiwo et al. (2012). Two micrograms of genomic DNA isolated from day
10 EBs was sonicated to 300 bp fragments using a Covaris S220 ultrasonica-
tor. One microgram of purified adaptor-ligated DNA was used for pooled
immunoprecipitations using a polyclonal 5mC-specific antibody (Active Motif;
39791). Details of MeDIP, library preparation, and data analysis are outlined in
Supplemental Experimental Procedures. Briefly, in order to quantitatively
analyze sequencing reads, position-wise read counts were normalized
according to the 5mC levels of each sample DNA, as determined by mass
spectroscopy. Differences in methylation levels for each gene in different sam-
ples were calculated by subtracting the normalized average read counts in
TKO samples from the respective WT values. If the difference was equal or
larger than 0.25, the region was considered hypermethylated in the TKO. If
the difference was equal or smaller than 0.25, the region was considered
hypomethylated.ACCESSION NUMBERS
The MeDIP sequencing data and gene-expression array data sets have been
deposited in the Gene Expression Omnibus database under accession
numbers GSE55049 and GSE55574, respectively.110 Developmental Cell 29, 102–111, April 14, 2014 ª2014 Elsevier ISUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, Supplemental Experimental
Procedures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2014.03.003.
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